Medical Advocates
Abacavir (Ziagen)
 
Main Page

New and Noteworthy 
Drug Alerts
Guidelines
 Database of ARV Drug Interactions
 Journal Data
 Conference Data
 Perinatal Index
 Pediatric Index
Trizivir
Epzicom

 
ARV Drugs Main Page Main New/Newsworthy Home Page
This web page is best viewed by using INTERNET EXPLORER
Last Update:  July 23, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
 ABC/3TC/ZDV data are indexed on the Trizivir Web
ABC/Fixed Dose 3TC data are indexed on the Epzicom Web
New and Noteworthy
     
July 2008
 
June 2008
 
Drug Alerts
         
Abacavir
 
 
FULL-TEXT DOCUMENT
 Abacavir Label Changes
 FDA
July 23, 2008

FULL TEXT  DOCUMENT
 Abacavir or Didanosine Associated with an Increased Risk of Myocardial Infarction
 USFDA  
March 27, 2008
 
  FULL TEXT  DOCUMENT
 Ziagen/Combivir Alert
 GlaxoSmithKline and FDA
March 2007 
 
Lamivudine/Abacavir/Tenofovir
 
  FULL-TEXT LETTER
 Early Virologic Non-Response in Patients with HIV Infection Treated With Lamivudine,
Abacavir and Tenofovir
Manion DJ,
July 2003

Abacavir/Lamivudine/Zidovudine (Trizivir)
 
  PDF NIAID ALERT
 Important Interim Results from a Phase III, Randomized, Double-Blind Comparison of
Three Protease-Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection
(AACTG Protocol A5095)
PDF File
 Trizavir Data
FDA Approvals
     
 
FDA Gives Tentative Approval to Generic AIDS Drug Abacavir
 FDA  May 16. 2006
 News Release

TRUVADA (tenofovir disoproxil/emtricitabine- fixed dose) and EPZICOM (abacavir sulfate
and  lamivudine-fixed dose) approved by US FDA on August 02, 2004
 August 02, 2004
News Release

ARV Drugs Main Page Main New/Newsworthy Home Page

Abacavir Main Page